Ulcerative Colitis & Crohn's Flashcards
Ulcerative Colitis Definition/Pathophysiology
Chronic idiopathic immune-mediated inflammatory condition of large intestine. Frequently associated with inflammation of rectum & often extends proximally to involve colon. Relapsing & remitting, with symptoms of active disease alternating with periods of remission.
UC Risk factors/prevention
Onset peaks between 15-30 years of age. Recent smoking cessation, NSAIDs, C.diff
UC Clinical Manifestations
Inflamed rectum (bleeding, urgency, tenesmus-sense of pressure)
abdominal cramping
weight loss
UC Diagnosis
Infectious etiology should be ruled out (C.diff)
Colonoscopy to include ileum & biopsies of affected/unaffected areas
UC Endoscopic Index of Severity looks at what 3 descriptors?
Vascular pattern
Bleeding
Erosions and ulcers
UC Management
Induction of remission: (Mild)
rectal 5-aminosalicylate 1g/d (+ po 5-aminosalicylate 2g/d if left-sided UC)
PO 5-aminosalicylate 2g/d if extensive UC
PO steroids if no remission (budesonide MMX 9mg/d)
UC Management
Maintenance (Mild)
rectal 5-aminosalicylate 1g/d
PO 5-aminosalicylate 2g/d if extensive UC or left-sided UC
UC Management
Induction of remission (Mod-Severe)
PO budesonide MMX
5-ASA (not in severe cases)
anti-TNF therapy
Vedolizumab (monoclonal Ab)
tofacitinib 10mg po BID x 8 weeks
anti-TNF therapy ioncludes what drugs?
adalimumab
golimumab
infliximab + thiopurine
UC Management
Maintenance (Mod-Severe)
thiopurines if used steroids for induction (azathioprine, mercaptopurine)
anti-TNF therapy
Vedolizumab
tofacitinib
UC Management (acute, hospitalized)
DVT prophylaxis
C. Diff testing
Vanco if C.diff
methylprednisolone 60mg/d or hydrocortisone 100 mg TID/qid to induce remission
UC prevention of colon cancer
colonoscopies q 1-3 years beginning 8 years after initial dx
Poor prognostic factors for UC
Age < 40 at dx
Extensive colitis
Severe endoscopic disease
Hospitalization for colitis
Elevated CRP
Low Serum Albumin
Crohn’s Definition/Pathophysiology
Idiopathic inflammatory d/o of UK etiology with genetic, immunologic, & environmental influences. Chronic, intermittent, progressive, destructive. Most present with non-penetrating, non-stricturizing dz. 50% develop intestinal comps (stricture, abscess, fistula, phlegmon) w/n 20 yrs of dx. Extensive anatomic involvement & deep ulcerations are other risk factors for progression to comps.
Crohn’s Risk Factors/prevention
Smoking & NSAIDs may exacerbate disease activity